PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
January 23, 2026Journal of Crohn s and Colitis

P1151Shortened Infliximab Infusion Times for Adult Inflammatory Bowel Disease (IBD) Patients at St Marks National Bowel Hospital

View Full Paper
Ask AI
Bookmark
Share

Authors

ASA ShaabanACA ChanaLYLisa Younge

Discussion

Loading...

Member takes

Overview

Proposes shortened infliximab infusion times in adults with inflammatory bowel disease, suggesting improved efficiency for treatment initiation.

Key Points

  • The aim is to evaluate the safety and efficiency of a new regimen with shorter infliximab infusion times for patients with inflammatory bowel disease.
  • Identified suitable patients in the IBD infusion unit for the new infusion regimen.
  • Administered first infliximab dose over 2 hours, followed by doses over 1 hour and subsequent doses over 30 minutes.
  • Documented infusion times, occurrence of infusion reactions, and treatments provided.
  • Collected data from 37 patients, with 26 completing three doses under the new regimen without infusion reactions.
  • Achieved a total time saving of approximately 50 hours compared to the standard schedule.
  • Only 3 patients (8.1%) experienced infusion-related reactions; two had prior exposure to infliximab, which was an oversight.

Cite This Study

Shaaban et al. (2026) studied this question.

synapsesocial.com/papers/69730f59c8125b09b0d1f303https://doi.org/10.1093/ecco-jcc/jjaf231.1332
View Full Paper
Ask AI
Bookmark
Share